Shionogi Of Japan Seeks To Acquire Chinese Maker Of Antibiotics
This article was originally published in PharmAsia News
Executive SummaryJapan's Shionogi plans to buy a Chinese drug maker by the end of fiscal 2010 to expand its product lines into antibiotics
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.